Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Asset Utilization Ratio readings, the most recent being 1.15 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 50.72% to 1.15 in Q1 2026 year-over-year; TTM through Mar 2026 was 1.15, a 50.72% decrease, with the full-year FY2025 number at 1.87, up 98.87% from a year prior.
  • Asset Utilization Ratio hit 1.15 in Q1 2026 for Atara Biotherapeutics, down from 4.79 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 4.79 in Q4 2025 to a low of 0.01 in Q2 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.61 (2024), compared with a mean of 1.39.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 67.88% in 2023 and later skyrocketed 5360.82% in 2024.
  • Atara Biotherapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then plummeted by 67.88% to 0.05 in 2023, then soared by 1908.42% to 1.02 in 2024, then skyrocketed by 367.94% to 4.79 in 2025, then crashed by 76.0% to 1.15 in 2026.
  • The last three reported values for Asset Utilization Ratio were 1.15 (Q1 2026), 4.79 (Q4 2025), and 4.53 (Q3 2025) per Business Quant data.